We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+8.43%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$34.3B
AUM Growth
+$4.15B
(+14%)
Cap. Flow
+$1.92B
Cap. Flow
% of AUM
5.6%
Top 10 Holdings %
Top 10 Hldgs %
23.44%
Holding
1,439
New
97
Increased
478
Reduced
443
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stellantis
STLA
|
+$200M |
| 2 |
Amazon
AMZN
|
+$126M |
| 3 |
Deutsche Bank
DB
|
+$109M |
| 4 |
Intuitive Surgical
ISRG
|
+$92.2M |
| 5 |
Wells Fargo
WFC
|
+$83.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$126M |
| 2 |
Abbott
ABT
|
+$79.1M |
| 3 |
VF Corp
VFC
|
+$49M |
| 4 |
JPMorgan Chase
JPM
|
+$48.5M |
| 5 |
BioNTech
BNTX
|
+$46.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Healthcare | 15.46% |
| 3 | Financials | 11.88% |
| 4 | Communication Services | 9.65% |
| 5 | Consumer Discretionary | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Morningstar
MORN
$7.54B
| $664K | ﹤0.01% |
2,641
| – | – |
|
1002
Revolution Medicines
RVMD
$44.4B
| $662K | ﹤0.01% |
21,000
| – | – |
|
1003
Coupang
CPNG
$29.1B
| $661K | ﹤0.01% |
+15,667
| New | +$642K |
|
1004
Rapid7
RPD
$776M
| $659K | ﹤0.01% |
6,970
| – | – |
|
|
RUBY
1005
DELISTED
Rubius Therapeutics, Inc
RUBY
| $659K | ﹤0.01% |
28,200
| – | – |
|
1006
BWX Technologies
BWXT
$15.5B
| $658K | ﹤0.01% |
11,515
| – | – |
|
|
JOYY
1007
JOYY Inc
JOYY
$3.77B
| $653K | ﹤0.01% |
9,528
-19,610
| -67% | -$1.66M |
|
1008
Diamondback Energy
FANG
$55.7B
| $652K | ﹤0.01% |
7,046
+576
| +9% | +$47.5K |
|
|
PFPT
1009
DELISTED
Proofpoint, Inc.
PFPT
| $650K | ﹤0.01% |
3,800
+1,000
| +36% | +$162K |
|
1010
Envista
NVST
$4.53B
| $642K | ﹤0.01% |
15,000
| – | – |
|
|
STOR
1011
DELISTED
STORE Capital Corporation
STOR
| $642K | ﹤0.01% |
18,732
-27,891
| -60% | -$971K |
|
|
EVBG
1012
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $639K | ﹤0.01% |
4,610
| – | – |
|
|
AMRN
1013
Amarin Corp
AMRN
$298M
| $638K | ﹤0.01% |
7,230
| – | – |
|
1014
ScottsMiracle-Gro
SMG
$3.63B
| $638K | ﹤0.01% |
3,339
-30
| -0.9% | -$6.62K |
|
|
TECX
1015
Tectonic Therapeutic
TECX
$639M
| $638K | ﹤0.01% |
5,917
-5,833
| -50% | -$691K |
|
1016
Autohome
ATHM
$2.71B
| $637K | ﹤0.01% |
9,762
-13,376
| -58% | -$1.1M |
|
1017
Endava
DAVA
$159M
| $632K | ﹤0.01% |
5,524
-2,276
| -29% | -$220K |
|
1018
Boyd Gaming
BYD
$5.92B
| $630K | ﹤0.01% |
+10,327
| New | +$651K |
|
1019
Cenovus Energy
CVE
$54.5B
| $629K | ﹤0.01% |
67,563
+22,220
| +49% | +$188K |
|
|
LMNX
1020
DELISTED
Luminex Corp
LMNX
| $627K | ﹤0.01% |
17,300
| – | – |
|
|
PSB
1021
DELISTED
PS Business Parks, Inc.
PSB
| $626K | ﹤0.01% |
4,294
| – | – |
|
1022
Radware
RDWR
$1.2B
| $624K | ﹤0.01% |
20,400
+7,250
| +55% | +$209K |
|
1023
Personalis
PSNL
$1.55B
| $620K | ﹤0.01% |
23,800
| – | – |
|
1024
PTC Therapeutics
PTCT
$6.23B
| $618K | ﹤0.01% |
14,900
| – | – |
|
1025
Supernus Pharmaceuticals
SUPN
$2.74B
| $617K | ﹤0.01% |
19,700
| – | – |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q2 2021 Portfolio in Review
As of Q2 2021, DekaBank Deutsche Girozentrale held 1,439 positions worth $34.3B, up 14% from $30.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
DekaBank Deutsche Girozentrale deployed $1.92B of net new capital in Q2 2021, opening 97 new positions and adding to 478 existing holdings. Its largest new stake was Stellantis: 10,647,151 shares worth $207M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Broadcom, an estimated $126M trimmed.
- DekaBank Deutsche Girozentrale's largest Q2 2021 buy was Stellantis: 10,647,151 shares worth $207M.
- DekaBank Deutsche Girozentrale added most to Amazon in Q2 2021, an estimated $126M increase.
- DekaBank Deutsche Girozentrale's biggest Q2 2021 reduction was Broadcom, cutting an estimated $126M.
- DekaBank Deutsche Girozentrale fully exited CureVac in Q2 2021, selling an estimated $6.93M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $34.3B portfolio in Q2 2021.
- DekaBank Deutsche Girozentrale opened 97 new positions and closed 54 in Q2 2021.
- DekaBank Deutsche Girozentrale's portfolio value rose 14% quarter-over-quarter to $34.3B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2021, filed 5 Aug 2021.